Idelalisib and caffeine reduce suppression of T cell responses mediated by activated chronic lymphocytic leukemia cells

Open Access

Peer-reviewed

Research Article

Barry D. Hock ,

* E-mail: barry.hock@otago.ac.nz

Affiliations Haematology Research Group, Christchurch Hospital, Christchurch, New Zealand, Pathology Department, University of Otago, Christchurch, New Zealand
⨯
Sean A. MacPherson,

Affiliations Pathology Department, University of Otago, Christchurch, New Zealand, Haematology Department, Christchurch Hospital, Christchurch, New Zealand
⨯
Judith L. McKenzie

Affiliations Haematology Research Group, Christchurch Hospital, Christchurch, New Zealand, Pathology Department, University of Otago, Christchurch, New Zealand
⨯

Reader Comments (0)

Caffeine
Is the Subject Area "Caffeine" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Chronic lymphoblastic leukemia
Is the Subject Area "Chronic lymphoblastic leukemia" applicable to this article?

Thanks for your feedback.
Adenosine
Is the Subject Area "Adenosine" applicable to this article?

Thanks for your feedback.
Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.
Flow cytometry
Is the Subject Area "Flow cytometry" applicable to this article?

Thanks for your feedback.
Immunosuppressives
Is the Subject Area "Immunosuppressives" applicable to this article?

Thanks for your feedback.
B cells
Is the Subject Area "B cells" applicable to this article?

Thanks for your feedback.